Bussum, Netherlands, August 5, 2009: Fifteen Bentham Science Journals improved their impact factor (click here) rankings, according to recently released Journal Citation Reports® 2008. Three new journals, Current Medical Imaging Reviews, Current Signal Transduction Therapy and CNS & Neurological Disorder – Drug Targets, registered impact factors for the first time reflecting the high quality of research published by Bentham Science.

Current Molecular Medicine topped the Bentham Science Impact factor list with an increase of 0.63 points to take its impact factor up to 5.254. Other important journals which gained impact factor were:

1. Current Cancer Drug Targets (IF: 4.316)
2. Current Medicinal Chemistry (IF: 4.823)
3. Current Pharmaceutical Design (IF: 4.399)
4. Current Drug Metabolism (IF: 4.350)
5. Current Topics in Medicinal Chemistry (IF: 4.268)
6. Current Drug Targets (IF: 4.187)
7. Current Alzheimer Research (IF: 4.132)

Journal Citation Report (JCR) is the most authentic information resource about scholarly journals published in various disciplines. It compiles results by critically evaluating the world's leading journals, with quantifiable, statistical information based on citation data. This report is published annually by the Institute of Scientific Information, a division of Thomson Reuters.

Bentham Science Publishers now publishes 90 print and online scholarly journals along with 200 plus open access publications. Bentham is also planning to launch 200 ebooks per year from 2009. Major fields covered by the journals published by Bentham Science Publishers includes science, technology, medicine, engineering, chemistry, life sciences and pharmaceutical science,. Bentham's journals have a large distribution and readership particularly in Europe, North America, Japan and Asia. For a detailed profile see website http://www.bentham.org